James J. Donohue - 17 Jun 2024 Form 4 Insider Report for Acurx Pharmaceuticals, Inc. (ACXP)

Role
Director
Signature
/s/ Kostantinos Skordalos, Power of Attorney For: James J. Donohue
Issuer symbol
ACXP
Transactions as of
17 Jun 2024
Transactions value $
$0
Form type
4
Filing time
18 Jun 2024, 16:11:34 UTC
Previous filing
16 Jun 2023
Next filing
08 Jan 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACXP Stock Option Award $0 +12K $0.00 12K 17 Jun 2024 Common Stock 12K $2.38 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option award is related to service on the Issuer's board of directors granted pursuant to the Issuer's Director Compensation Policy. The shares subject to the options shall vest on June 17, 2025.